Giacomo Gorini
Senior Research Associate
My current work, kindly supported by Oxford Science Enterprises, focusses on the development of novel technologies to rapidly generate monoclonal antibodies targeting traditionally difficult targets, such as membrane receptors and ion channels.
In the past, I dedicated my research efforts to the molecular study of antibody responses to vaccines against infectious agents such as HIV, HCV, P. falciparum and SARS-CoV-2.
I am passionate about the development of novel biotechnologies, student mentoring and science communication.
